Jonas Haggstrom (Cytel)
The COVID-19 pandemic is the greatest health challenge for a generation and has highlighted the critical importance of generating rapid and rigorous evidence for decision-making for the treatment of COVID-19. As a response to this challenge the International COVID-19 Data Alliance (ICODA) was formed, an open and inclusive global coordinated, health data-led research initiative bringing together for- and non-profit companies and organisations working collaboratively to enable and empower researchers to access RCT and RWD health data in a responsible way, making use of innovative data science, contemporary tools and technology to accelerate knowledge of the prevention and treatment of COVID-19. This talk will be in two parts; the first will be less technical in its nature and focus on the ICODA journey from its inauguration in July 2020 to the current state with 12 driver projects, including more than 130 researchers, working on data from over 40 different countries – the ins and outs of how to successfully bringing different companies and non-profit organisations to collaborate towards a common goal, and specifically how statistician played an essential role to make it happen. The second part will present results from one of the ICODA projects evaluating the efficacy and safety of COVID-19 of existing medical interventions to support drug repurposing efforts.